Systemic Candidiasis
Systemic candidiasis is the spread of Candida yeast through the bloodstream into organs such as the heart, brain, eyes, and bones. It occurs mainly in hospitalized or severely immunocompromised patients.
Key points
- Invasive candidiasis is distinct in severity from the more common mucosal forms that affect the vagina, mouth, or throat.
- Fever and chills are common presenting symptoms, but the full picture depends on which organs are involved, and symptoms can be hard to isolate because affected patients are already seriously ill.
- Candidiasis, including invasive forms, is treated with antifungal medications, and the type, dose, and duration depend on the severity of infection and the patient’s underlying health conditions.
Medicines listed for Systemic Candidiasis
The listed products contain fluconazole (Diflucan) and voriconazole (Vfend), both antifungal tablets. Fluconazole is available in strengths from 50 mg to 400 mg; voriconazole is listed at 200 mg. These azole antifungals are used to treat systemic candidiasis, and the choice between them depends on the species involved and the patient’s clinical context.

